Home/Filings/4/0001493152-23-000224
4//SEC Filing

SNYDER DAVID S 4

Accession 0001493152-23-000224

CIK 0001835022other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:30 AM ET

Size

6.9 KB

Accession

0001493152-23-000224

Insider Transaction Report

Form 4
Period: 2023-01-03
SNYDER DAVID S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2023-01-03+7,0007,000 total
  • Purchase

    Warrant to Purchase Common Stock

    2023-01-03+3,5003,500 total
    Exercise: $7.50From: 2023-01-03Exp: 2025-01-03Common Stock, par value $0.0001 per share (3,500 underlying)
Footnotes (1)
  • [F1]Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.

Documents

1 file

Issuer

Coya Therapeutics, Inc.

CIK 0001835022

Entity typeother

Related Parties

1
  • filerCIK 0001398625

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:30 AM ET
Size
6.9 KB